HTG MOLECULAR DIAGNOSTICS, INC

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$24.5M

389 transactions

Summary

HTG MOLECULAR DIAGNOSTICS, INC is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $14.1MSales: $8.5M27 insiders

Date	Insider	Type	Value
2023-06-08	Barat Stephen(Senior VP of Therapeutics)	Sell	$710.4
2022-06-10	Lawson Byron(SVP/Chief Commercial Officer)	A	$480
2022-12-09	Godlewski Laura Lee(SVP Finance & Administration)	A	$430
2022-12-09	McMeans Shaun D(SVP, Finance & Admin. & CFO)	A	$430
2022-12-09	Lubniewski John L(President & CEO)	A	$430
2022-12-09	Lawson Byron(SVP/Chief Commercial Officer)	A	$430
2023-03-31	Barat Stephen(Senior VP of Therapeutics)	F	$140.4
2022-06-30	Lubniewski John L(President & CEO)	F	$62.83
2022-06-30	McMeans Shaun D(SVP, Finance & Admin. & CFO)	F	$29.87
2022-06-30	Lawson Byron(SVP/Chief Commercial Officer)	F	$23.69
2022-09-15	HANHAM ANN	A	$0
2022-09-15	HARDISON DON M	A	$0
2022-09-15	McCracken Lee R.	A	$0
2022-09-15	GRIFFIN MICHELLE RENEE	A	$0
2022-09-15	KIRITSY CHRISTOPHER P	A	$0
2022-08-18	Dubensky Thomas W.	A	$0
2022-08-18	Lubniewski John L(President & CEO)	A	$0
2022-08-18	McMeans Shaun D(SVP, Finance & Admin. & CFO)	A	$0
2022-08-18	Godlewski Laura Lee(SVP Finance & Administration)	A	$0
2022-08-18	Lawson Byron(SVP/Chief Commercial Officer)	A	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

HTG MOLECULAR DIAGNOSTICS, INC — Contributions, Lobbying & Contracts | Poliscope